< Back to search
Filter
1

Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial

for
Advanced Acral Melanoma, Advanced Cutaneous Melanoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07155317

Phase2, Recruiting

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

for
Cutaneous Squamous Cell Carcinoma,
Location: Uniondale NY, New York NY, Middletown NJ, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05859074

Phase1, Recruiting

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

for
Cutaneous Melanoma, Cutaneous Melanoma, Stage III,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07148245

Recruiting

Tebentafusp-tebn With LDT in Metastatic UM

for
Metastatic Uveal Melanoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT06626516

Phase1, Phase2, Recruiting

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

for
Renal Cell Carcinoma, Non Small Cell Lung Cancer, Melanoma,
Location: Pittsburgh PA
Sponsor: Diwakar Davar

Sex: All

Age: 18+

Code: NCT07223424

Phase2, Recruiting

Interested in new melanoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: New York NY, New Brunswick NJ, Morristown NJ,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase1, Recruiting

Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

for
Locally Advanced Melanoma
Location: Pittsburgh PA
Sponsor: John Kirkwood

Sex: All

Age: 18+

Code: NCT07223411

Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Philadelphia PA, Wilson NC, Durham NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

Intratumoral N17350 in Advanced Solid Tumors

for
Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative,
Location: Buffalo NY
Sponsor: Onchilles Pharma Inc

Sex: All

Age: 18+

Code: NCT07339176

Phase1, Phase2, Recruiting

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

for
Breast Cancer, Ovarian Cancer, Cervical Cancer,
Location: Pasadena CA
Sponsor: Kaiser Permanente

Sex: All

Age: 21 - 45

Code: NCT07406087

Recruiting

Adjuvant Tebentafusp in High Risk Ocular Melanoma

for
Uveal Melanoma
Location: Lake Success NY
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT06246149

Phase3, Recruiting

Neoadjuvant Darovasertib in Primary Uveal Melanoma

for
Uveal Melanoma
Location: New York NY, Baltimore MD, Toronto, Jacksonville FL,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07015190

Phase3, Recruiting

Neoadjuvant Tebentafusp for Uveal Melanoma

for
Locally Advanced Unresectable Uveal Melanoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT06414590

Phase2, Recruiting

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

for
Melanoma (Skin Cancer), Melanoma Stage IIIB-IV,
Location: Boston MA, Philadelphia PA, Tampa FL, Aurora CO,
Sponsor: Linnaeus Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06624644

Phase2, Phase3, Recruiting

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

for
Clinical Stage 0 Cutaneous Melanoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03819296

Phase1, Recruiting

ACTengine® IMA203 Combined With mRNA-4203

for
Cutaneous Melanoma, Synovial Sarcoma
Location: Boston MA, New York NY, Houston TX, San Francisco CA
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06946225

Phase1, Recruiting

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

for
Melanoma, Brain Metastases
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06712927

Phase2, Recruiting

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

for
Metastatic Melanoma, Advanced Melanoma
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07504796

Phase2, Recruiting

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

for
Solid Tumor, Adult, Solid Tumor, Melanoma, Basal Cell Cancer,
Location: Denver CO, Nashville TN
Sponsor: Rise Therapeutics LLC

Sex: All

Age: 18 - 70+

Code: NCT06398418

Phase1, Recruiting

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

for
Metastatic Melanoma, OligoProgressive Metastatic Disease
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07112170

Recruiting